DarioHealth (Formerly Known As LabStyle Innovations)
About DarioHealth (Formerly Known As LabStyle Innovations)
DarioHealth Corp. (NASDAQ: DRIO) creates innovative mobile and digital tools that empower and engage users to lead healthier lives. DarioHealth’s “Real time. Real data. Real people” approach and strategy is positioning the company as a major player in the mHealth industry; an industry currently worth $10B and expected to reach $31B by 2020*. DarioHealth’s flagship product, the Dario™ Smart Diabetes Management Solution, is a platform for diabetes management that combines an all-in-one blood glucose meter, native smart phone app (iOS & Android), website portal and a wide variety of treatment tools to support more proactive and better informed decisions by users living with diabetes, their doctors and healthcare systems.The Dario Smart Diabetes Management Solution was granted U.S. FDA marketing clearance in December 2015 and is set to launch in the current quarter in the U.S. – the largest market in the world for glucose monitoring. LabStyle has been granted patents, and is pursuing additional applications - in multiple areas covering the specific processes related to blood glucose level measurement, as well as more general methods for rapid body fluids testing using mobile devices and cloud-based services. Dario™ is currently available in the UK, New Zealand, Netherlands, Australia, Israel, Canada, Belgium and Italy. Dario received reimbursement coverage in the UK, Australia, Israel, Italy and Canada. Sequential quarterly revenues are growing rapidly, reflecting strong market adoption.
LEADERSHIP:
CEO: Erez Raphael
CFO: Zvi Ben-David
214 articles about DarioHealth (Formerly Known As LabStyle Innovations)
-
DarioHealth Reports First Quarter 2020 Results
5/12/2020
Continued transformation to a software as a service (SaaS)-based membership model with recurring revenues and higher margin profile Established partnership with Vitality Group to accelerate penetration into the self-insured employer market Expanded offering to include behavioral health coaching and full suite of telemedicine capabilities Positioned platform to potentially drive substantial revenue growth in the second half of this year Company to Host Conf
-
DarioHealth Self-test Blood Glucose Meters Can Now Be Utilized Within Hospitals During the COVID-19 Pandemic Per Recently Issued Emergency FDA Guidelines
5/6/2020
DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. Food and Drug Administration (FDA) has recognized that home-use
-
DarioHealth to Report Financial Results for the First Quarter 2020 Results on May 12
5/5/2020
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its first quarter ended March 31, 2020 financial results on Tuesday, May 12, 2020 , and host
-
DarioHealth Expands Offering to Include Behavioral Health
5/4/2020
DarioHealth Corp. (Nasdaq: DRIO), a leading global digital therapeutics (DTx) innovator, announced today that it has expanded its offering on its chronic care platform application to include behavioral health coaching for stress, anxiety and loneliness, conditions which have recently escalated due to COVID-19 social distancing restriction
-
DarioHealth Expands Remote Care Offering With Integration of Full-Service Telemedicine
4/29/2020
Partnership with global telemedicine leader MediOrbis creates a social distancing compliant, complete care Dario solution
-
Dario Diabetes Management Is Recognized as a Leading Application for Children/Young People Self-managing Healthcare During COVID-19 Pandemic
3/25/2020
DarioHealth® Receives Endorsement from the Organization for the Review of Care & Health Applications (ORCHA)
-
DarioHealth Enters Into a Partnership With Vitality to Accelerate Penetration Into the Self-insured Employer Market
3/24/2020
DarioHealth Corp. (Nasdaq: DRIO) ("Dario") a pioneer in the global digital therapeutics market, announced today that it has entered into a partnership with Vitality Group, a global health and wellness company committed to making people healthier. Under the partnership, Vitality will integrate Dario's digital therapeutics for chronic c
-
DarioHealth Reports Fourth Quarter and Year End 2019 Results
3/17/2020
DarioHealth Corp. reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate and commercial update.
-
DarioHealth to Host Fourth Quarter 2019 Conference Call March 17, 2020
3/12/2020
Global digital therapeutics innovation leader DarioHealth Corp. announced it will release its fourth quarter and year end 2019 results on Tuesday, March 17, and host a conference call the same morning at 8:30 am EDT..
-
BioSpace Movers & Shakers, March 6
3/6/2020
Life sciences and pharma companies from across the globe strengthen their leadership teams and board with this week's Movers & Shakers. -
DarioHealth Appoints Two New Board Members
3/5/2020
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the company has appointed Yadin Shemmer and Adam K. Stern to serve as board members effective immediately until t
-
DarioHealth Digital Diabetes Management System is Now Available at Albertsons
2/24/2020
NEW YORK , Feb. 24, 2020 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace . Albertsons Companies is one of the largest reta
-
DarioHealth® Presents New Clinical Study Outcomes Showing the Dario Digital Therapeutics Platform Helps Insulin Dependent Patients With Diabetes Better Manage Their Chronic Condition
2/19/2020
Patients Significantly Reduced Hypoglycemic and High Glycemic Events by 50% and 40%, respectively, over a Two-Year Period
-
DarioHealth Strengthens Management Team With Appointment of Digital Health Veteran Rick Anderson as President and General Manager, North America
1/9/2020
Expertise Sharpens Dario's Focus on Execution and Expansion within the U.S. B2B Channel
-
Walmart Starts Distributing the DarioHealth Digital Diabetes Management System
12/3/2019
Global digital therapeutics innovation leader, DarioHealth Corp. announced the launch of the Dario-powered digital diabetes program on Walmart.com.
-
DarioHealth® Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes
11/15/2019
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting ("DTM") conference in Bethesda, Maryland
-
DarioHealth Corp. CEO Erez Raphael Invited to Participate in BTIG Digital Health 2019
11/14/2019
DarioHealth Corp. (NASDAQ: DRIO) ("DarioHealth" or "Dario"), a leading, global digital therapeutics company, today announced that Dario's CEO, Erez Raphael, will be participating in a panel discussion at BTIG Digital Health 2019: Industry Innovators on What's Next, on Wednesday, November 20, 2019.
-
DarioHealth Reports Results for Third Quarter 2019
10/28/2019
Global digital therapeutics innovator DarioHealth Corp., reported financial and operational results for the third quarter ended September 30, 2019.
-
DarioHealth Appoints Digital Therapeutics Pioneer Dr. Abigail Hirsch to Its Advisory Board to Support Commercial Strategy and Execution
10/22/2019
DarioHealth Corp., a leading, global digital therapeutics company, has appointed Dr. Abigail Hirsch to its Advisory Board where she will help guide commercial and Business-to-Business efforts..
-
DarioHealth to Host Third Quarter 2019 Conference Call October 28, 2019
10/17/2019
Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its third quarter 2019 results on Monday, October 28, and host a conference call the same morning at 9:00 am EDT.